Cargando…
Targeting VEGF/VEGFR to Modulate Antitumor Immunity
In addition to the crucial role in promoting the growth of tumor vessels, vascular endothelial growth factor (VEGF) is also immunosuppressive. VEGF can inhibit the function of T cells, increase the recruitment of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), and hinder the...
Autores principales: | Yang, Ju, Yan, Jing, Liu, Baorui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943566/ https://www.ncbi.nlm.nih.gov/pubmed/29774034 http://dx.doi.org/10.3389/fimmu.2018.00978 |
Ejemplares similares
-
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
por: Yang, Ju, et al.
Publicado: (2019) -
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
por: Yang, Gui-Li, et al.
Publicado: (2018) -
Structure-Based Design of Peptides Targeting VEGF/VEGFRs
por: Di Stasi, Rossella, et al.
Publicado: (2023) -
Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
por: Li, Yu-Ling, et al.
Publicado: (2016) -
Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway
por: Li, Xiao, et al.
Publicado: (2022)